antiRPS4Y1 mAb
It forms an object of the present invention a monoclonal antibody or an antigen-binding fragment thereof, which specifically binds to RPS4Y1 protein, preferably to human RPS4Y1, recognizing an epitope comprising sequence Y1 (SEQ ID NO: 3), and/or sequence Y2 (SEQ ID NO: 4) and/or sequence Y3 (SEQ ID...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
17.08.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | It forms an object of the present invention a monoclonal antibody or an antigen-binding fragment thereof, which specifically binds to RPS4Y1 protein, preferably to human RPS4Y1, recognizing an epitope comprising sequence Y1 (SEQ ID NO: 3), and/or sequence Y2 (SEQ ID NO: 4) and/or sequence Y3 (SEQ ID NO: 5) of RPS4Y1.In a further embodiment, it is here claimed a non-invasive method to identify male foetal cells within three months of gestation, said method comprising detecting the presence of RPS4Y1 protein in a maternal biological tissue sample by an antibody or an antigen-binding fragment thereof, according to the present invention.Classes: G01N33, Y105436 |
---|---|
Bibliography: | Application Number: US202217673912 |